Following the Doha and Paris mediation, Qatar and Israel announced on Tuesday an agreement to allow the delivery of medicines to captives in Gaza as well as supplies into the region.
Doha confirmed the pact between Israel and Hamas, where medicine along with other humanitarian aid is to be delivered to civilians in Gaza… in exchange for delivering medication needed for Israeli captives in Gaza in a statement.
The office of Israeli Prime Minister Benjamin Netanyahu acknowledged the agreement, stating that the medicines would be forwarded by Qatari representatives in the Gaza Strip to their final destination.
The medications are intended for 45 captives, according to the French president, who stated that 83 were initially classified as requiring medication in November, but 38 have since been released or executed.
When the drugs arrive at a hospital in the southern Gaza border town of Rafah on Wednesday, they will be received by the International Committee of the Red Cross, separated into batches, and promptly delivered to the hostages.
The deliveries will continue for three months and were managed by the French foreign ministry’s crisis centre, which purchased the pharmaceuticals and transported them to Doha on Saturday via diplomatic pouch, according to Philippe Lalliot, the centre’s director.
Qatar, which hosts Hamas’ political office, has led discussions between Israel and the Palestinian group, mediating a week-long truce in Gaza in November that resulted in the release of dozens of Israeli and international hostages.
The conflict erupted following an enormous Hamas attack on October 7, which killed around 1,140 persons in Israel.
Operatives also hauled roughly 250 hostages back to Gaza, 132 of whom Israel believes are still there, with at least 27 thought to have been killed.
Since October 7, Israeli bombardments and a military invasion have killed at least 24,285 Palestinians in the Gaza Strip, more than 70% of them are women and children.
Also read: Stock Markets Halt Their 5-Day Winning Streak On Profit-Taking In IT Equities And Poor Global Cues
